The Antibacterial Activities of Secondary Metabolites Derived from Streptomyces sp.

The spreading of infectious diseases caused by the emergence of Multidrug-Resistant (MDR) pathogens is a global threat that has led to numerous deaths annually. In view of this, there is an overwhelming need to discover new bioactive compounds with effective antimicrobial properties. Concurrently,...

Full description

Saved in:
Bibliographic Details
Main Authors: Rabia Mrehil Elsalam, Khang Wen Goh, Mahani Mahadi, Najwa Mohammad, Yaman Walid Kassab, Noraziah Mohamad Zin, Kok-Yong Chin
Format: Article
Language:English
Published: HH Publisher 2022-12-01
Series:Progress in Microbes and Molecular Biology
Online Access:https://journals.hh-publisher.com/index.php/pmmb/article/view/674
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832541407017959424
author Rabia Mrehil Elsalam
Khang Wen Goh
Mahani Mahadi
Najwa Mohammad
Yaman Walid Kassab
Noraziah Mohamad Zin
Kok-Yong Chin
author_facet Rabia Mrehil Elsalam
Khang Wen Goh
Mahani Mahadi
Najwa Mohammad
Yaman Walid Kassab
Noraziah Mohamad Zin
Kok-Yong Chin
author_sort Rabia Mrehil Elsalam
collection DOAJ
description The spreading of infectious diseases caused by the emergence of Multidrug-Resistant (MDR) pathogens is a global threat that has led to numerous deaths annually. In view of this, there is an overwhelming need to discover new bioactive compounds with effective antimicrobial properties. Concurrently, the genus Streptomyces has a growing reputation as a potential biological source of various antibiotics and other bioactive metabolites. Streptomyces sp. has been isolated from different sources, including terrestrial and marine habitats with a myriad of promising compounds that could be used to treat MDR pathogens. Therefore, this study presents a systematic review of the antibacterial activities of Streptomyces-derived secondary metabolites. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and checklist were employed in this study to collect relevant articles from two research databases, namely PubMed and Science Direct. The selection process includes identification, screening, eligibility, and inclusion of articles. Several keywords and criteria were established for the screening and selection process. Based on the results, a total of 26 articles were selected from 70 potential articles. The articles were published between 2015 and 2020 with most studies being published in 2020, indicating an increased interest in Streptomyces and its derived compounds. Approximately 51 different PMMB 2022, 5, 1; a0000281 2 of 25 Streptomyces-derived compounds have been identified, ranging from crude extracts, pure compounds, and partially purified compounds. Various parameters were also used to assess their antibacterial activities, particularly the Minimum Inhibitory Concentration (MIC) (69%) and the zone of inhibition (11%). Moreover, the antibacterial activities of these compounds were effective on numerous gram-positive and gram-negative bacteria. Furthermore, 46% and 54% of the selected studies were focused on inhibiting MDR and nonMDR pathogens, respectively. In conclusion, both crude and purified compounds from Streptomyces sp. exhibited strong antibacterial effects. It is expected that extensive future research would develop a standard method to compare the antibacterial strength of each extracted compound from Streptomyces sp. and determine the most effective bioactive compounds to treat diseases caused by MDR pathogens.
format Article
id doaj-art-6983a9a7231e47dda4fde7cfa066221a
institution Kabale University
issn 2637-1049
language English
publishDate 2022-12-01
publisher HH Publisher
record_format Article
series Progress in Microbes and Molecular Biology
spelling doaj-art-6983a9a7231e47dda4fde7cfa066221a2025-02-04T08:40:02ZengHH PublisherProgress in Microbes and Molecular Biology2637-10492022-12-015110.36877/pmmb.a0000281The Antibacterial Activities of Secondary Metabolites Derived from Streptomyces sp. Rabia Mrehil ElsalamKhang Wen GohMahani MahadiNajwa MohammadYaman Walid KassabNoraziah Mohamad ZinKok-Yong Chin The spreading of infectious diseases caused by the emergence of Multidrug-Resistant (MDR) pathogens is a global threat that has led to numerous deaths annually. In view of this, there is an overwhelming need to discover new bioactive compounds with effective antimicrobial properties. Concurrently, the genus Streptomyces has a growing reputation as a potential biological source of various antibiotics and other bioactive metabolites. Streptomyces sp. has been isolated from different sources, including terrestrial and marine habitats with a myriad of promising compounds that could be used to treat MDR pathogens. Therefore, this study presents a systematic review of the antibacterial activities of Streptomyces-derived secondary metabolites. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and checklist were employed in this study to collect relevant articles from two research databases, namely PubMed and Science Direct. The selection process includes identification, screening, eligibility, and inclusion of articles. Several keywords and criteria were established for the screening and selection process. Based on the results, a total of 26 articles were selected from 70 potential articles. The articles were published between 2015 and 2020 with most studies being published in 2020, indicating an increased interest in Streptomyces and its derived compounds. Approximately 51 different PMMB 2022, 5, 1; a0000281 2 of 25 Streptomyces-derived compounds have been identified, ranging from crude extracts, pure compounds, and partially purified compounds. Various parameters were also used to assess their antibacterial activities, particularly the Minimum Inhibitory Concentration (MIC) (69%) and the zone of inhibition (11%). Moreover, the antibacterial activities of these compounds were effective on numerous gram-positive and gram-negative bacteria. Furthermore, 46% and 54% of the selected studies were focused on inhibiting MDR and nonMDR pathogens, respectively. In conclusion, both crude and purified compounds from Streptomyces sp. exhibited strong antibacterial effects. It is expected that extensive future research would develop a standard method to compare the antibacterial strength of each extracted compound from Streptomyces sp. and determine the most effective bioactive compounds to treat diseases caused by MDR pathogens. https://journals.hh-publisher.com/index.php/pmmb/article/view/674
spellingShingle Rabia Mrehil Elsalam
Khang Wen Goh
Mahani Mahadi
Najwa Mohammad
Yaman Walid Kassab
Noraziah Mohamad Zin
Kok-Yong Chin
The Antibacterial Activities of Secondary Metabolites Derived from Streptomyces sp.
Progress in Microbes and Molecular Biology
title The Antibacterial Activities of Secondary Metabolites Derived from Streptomyces sp.
title_full The Antibacterial Activities of Secondary Metabolites Derived from Streptomyces sp.
title_fullStr The Antibacterial Activities of Secondary Metabolites Derived from Streptomyces sp.
title_full_unstemmed The Antibacterial Activities of Secondary Metabolites Derived from Streptomyces sp.
title_short The Antibacterial Activities of Secondary Metabolites Derived from Streptomyces sp.
title_sort antibacterial activities of secondary metabolites derived from streptomyces sp
url https://journals.hh-publisher.com/index.php/pmmb/article/view/674
work_keys_str_mv AT rabiamrehilelsalam theantibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT khangwengoh theantibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT mahanimahadi theantibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT najwamohammad theantibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT yamanwalidkassab theantibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT noraziahmohamadzin theantibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT kokyongchin theantibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT rabiamrehilelsalam antibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT khangwengoh antibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT mahanimahadi antibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT najwamohammad antibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT yamanwalidkassab antibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT noraziahmohamadzin antibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp
AT kokyongchin antibacterialactivitiesofsecondarymetabolitesderivedfromstreptomycessp